An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan. (Q47615376)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

0 references

1 reference

based on heuristic

inferred from title

Yoshihiro Tadori

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

Hironobu Ichikawa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Michio Hiratani

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Akihiro Yasuhara

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Noa Tsujii

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Takashi Oshimo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Hiroaki Ono

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

publication date

8 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Psychiatry and Clinical Neurosciences

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

72

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

84-94

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912.

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Safety and pharmacokinetics of atypical antipsychotics in children and adolescents

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Aripiprazole in the Treatment of Irritability in Pediatric Patients (Aged 6–17 Years) with Autistic Disorder: Results from a 52-Week, Open-Label Study

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study.

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Factor validity and reliability for the Aberrant Behavior Checklist-Community in a Japanese population with mental retardation.

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

A children's global assessment scale (CGAS)

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12607

21 January 2018

Identifiers

10.1111/PCN.12607

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28941259%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47615376&oldid=1865175357"